InvestorsHub Logo
Followers 833
Posts 119895
Boards Moderated 17
Alias Born 09/05/2002

Re: None

Thursday, 09/06/2018 11:18:26 AM

Thursday, September 06, 2018 11:18:26 AM

Post# of 427
NVS sells US small-molecule-generics business to India’s Aurobindo for $900M plus $100M in contingent payments:

https://in.reuters.com/article/us-novartis-sandoz-aurobindo-pharma/novartis-sells-u-s-generics-assets-to-indias-bargain-hunting-aurobindo-idINKCN1LM0D4

Such a low price for this business would have been unthinkable a few years ago.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVS News